MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Abbott Laboratories

Închisă

SectorSănătate

131.66 -0.32

Rezumat

Modificarea prețului

24h

Curent

Minim

131.22

Maxim

133.52

Indicatori cheie

By Trading Economics

Venit

7.6B

9.2B

Vânzări

339M

11B

P/E

Medie Sector

17.363

63.778

EPS

1.34

Randament dividend

1.78

Marjă de profit

84.099

Angajați

114,000

EBITDA

82M

3B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+6.28% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.78%

2.39%

Următoarele câștiguri

16 apr. 2025

Data viitoare de dividende

15 mai 2025

Următoarea dată ex-dividende

15 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

7.8B

230B

Deschiderea anterioară

131.98

Închiderea anterioară

131.66

Sentimentul știrilor

By Acuity

27%

73%

81 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Abbott Laboratories Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 ian. 2025, 19:03 UTC

Câștiguri

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 ian. 2025, 18:20 UTC

Câștiguri

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 ian. 2025, 12:45 UTC

Câștiguri

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

1 nov. 2024, 14:15 UTC

Principalele dinamici ale pieței

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 nov. 2024, 10:10 UTC

Principalele dinamici ale pieței

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 oct. 2024, 23:57 UTC

Acțiuni populare

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 oct. 2024, 23:14 UTC

Principalele dinamici ale pieței

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 oct. 2024, 12:03 UTC

Câștiguri

Abbott Laboratories 3Q Sales Top Expectations

1 feb. 2025, 18:14 UTC

Top știri

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 ian. 2025, 16:40 UTC

Top știri
Câștiguri

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 ian. 2025, 15:20 UTC

Câștiguri

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 ian. 2025, 15:08 UTC

Câștiguri

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ian. 2025, 13:51 UTC

Câștiguri

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 ian. 2025, 13:39 UTC

Top știri
Câștiguri

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ian. 2025, 12:02 UTC

Câștiguri

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 ian. 2025, 12:01 UTC

Câștiguri

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 ian. 2025, 12:01 UTC

Câștiguri

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q Net $9.23B >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q Sales $10.97B >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q Organic Sales Growth Up 8.8% >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q EPS $5.27 >ABT

22 ian. 2025, 12:00 UTC

Câștiguri

Abbott Labs 4Q Adj EPS $1.34 >ABT

22 ian. 2025, 09:54 UTC

Acțiuni populare

Stocks to Watch Wednesday: Netflix, Oracle, Trump Media, Softbank -- WSJ

1 nov. 2024, 17:33 UTC

Market Talk

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 oct. 2024, 14:21 UTC

Top știri
Câștiguri

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 oct. 2024, 12:25 UTC

Câștiguri

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 oct. 2024, 12:02 UTC

Top știri
Câștiguri

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 oct. 2024, 11:59 UTC

Câștiguri

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 oct. 2024, 11:37 UTC

Câștiguri

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

Comparație

Modificare preț

Abbott Laboratories Așteptări

Obiectiv de preț

By TipRanks

6.28% sus

Prognoză pe 12 luni

Medie 140.21 USD  6.28%

Maxim 158 USD

Minim 117 USD

În baza a 16 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAbbott Laboratories - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

16 ratings

14

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

126.38 / 132.65Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

81 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.